Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

NCT02664389 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
289
Enrollment
OTHER
Sponsor class

Stopped Difficulty in enrolling patients

Conditions

Interventions

Sponsor

University Hospital, Rouen